InvestorsHub Logo
Followers 15
Posts 1333
Boards Moderated 0
Alias Born 07/27/2015

Re: Amatuer17 post# 84452

Wednesday, 12/14/2016 8:04:08 PM

Wednesday, December 14, 2016 8:04:08 PM

Post# of 463764
Same could be said about Axovant. Employees may be a little higher.

They got the patent rights for their molecule from one glaxosmithkline who deemed it "sold to the only bidder", and by the way, before you purchase it, please know that it failed a ph3 already.

The only people that will be rich is the hedge funds that are in this gimmick. Fleecing the investors along the way.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News